Coca-Cola Europacific Partners Plc (CCEP) concluded trading on Wednesday at a closing price of $84.69, with 4.59 million shares of worth about $389.11 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.22% during that period and on March 05, 2025 the price saw a loss of about -1.32%. Currently the company’s common shares owned by public are about 474.92M shares, out of which, 206.10M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of -1.61% in past 5 days and over the past one month there was a price change of 8.35%. Year-to-date (YTD), CCEP shares are showing a performance of 10.26% which increased to 22.03% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $65.94 but also hit the highest price of $88.39 during that period. The average intraday trading volume for Coca-Cola Europacific Partners Plc shares is 1.66 million. The stock is currently trading 0.33% above its 20-day simple moving average (SMA20), while that difference is up 6.30% for SMA50 and it goes to 9.69% higher than SMA200.
Coca-Cola Europacific Partners Plc (NASDAQ: CCEP) currently have 474.92M outstanding shares and institutions hold larger chunk of about 33.49% of that.
The stock has a current market capitalization of $38.99B and its 3Y-monthly beta is at 0.72. PE ratio of stock for trailing 12 months is 25.41, while it has posted earnings per share of $3.33 in the same period. Its PEG reads 3.25 and has Quick Ratio of 0.62 while making debt-to-equity ratio of 1.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCEP, volatility over the week remained 2.06% while standing at 1.69% over the month.
Stock’s fiscal year EPS is expected to rise by 5.17% while it is estimated to increase by 8.37% in next year. EPS is likely to grow at an annualized rate of 7.82% for next 5-years, compared to annual growth of 4.96% made by the stock over the past 5-years.
On December 03, 2024, Bernstein Initiated their recommendations, while on November 27, 2024, JP Morgan Downgrade their ratings for the stock with a price target of $82. Stock get a Neutral rating from Exane BNP Paribas on September 10, 2024.
